Moreover, in AML (M1) ALDHhi/CD34+ cells, IER5 over-expression or TMPP treatment indicated an increase in the percentage of cells in S and G2/M compared to control cells (Fig 5D). The gene discussed is IER5; the disease is acute myeloid leukemia.